TNO and FAST (Financiering en Acceleratie voor Therapieontwikkeling) have launched a strategic collaboration to accelerate the development of advanced therapies, including ATMPs, radiopharmaceuticals, treatments for rare diseases, infectious diseases, and drug repurposing.
Highlights:
Shared ambition to accelerate drug discovery by leveraging TNO’s innovation capabilities and deep collaborations with industry, government, and society.
Conny Helder (former Minister of Health) appointed as FAST’s new board chair, bringing strong leadership and signalling a strengthened link with TNO in publicly funded therapy programmes.
This partnership combines TNO’s technical and operational strength with FAST’s independent expert role, aiming to scale innovations that are both effective and affordable for patients.
Read more here
University Campus Spui, Leiden University’s fourth location in The Hague, is about to open its doors. The transformation of the former V&D department store into a university...
Biotech start-up Bionomic from Oegstgeest (South Holland) won the Innovation Promise Award on Friday during the twentieth edition of the announcement of the KVK Innovation Top...
The Dutch Life Sciences Conference 2025 was held on 20 November 2025 at the CORPUS Congress Centre in Oegstgeest, bringing together biotech and medtech companies, academic...